Clinical importance of thrombocytopenia occurring in the hospital phase after administration of thrombolytic therapy for acute myocardial infarction
- 15 March 1994
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 23 (4), 891-898
- https://doi.org/10.1016/0735-1097(94)90634-3
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Hemorrhagic Complications of Thrombolytic Therapy in the Treatment of Myocardial Infarction and Venous ThromboembolismChest, 1992
- Hemorrhagic Events during Therapy with Recombinant Tissue-Type Plasminogen Activator, Heparin, and Aspirin for Acute Myocardial InfarctionAnnals of Internal Medicine, 1991
- Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction--phase 5 randomized trial. TAMI Study Group.Circulation, 1991
- Platelets and Thrombolytic TherapyNew England Journal of Medicine, 1990
- Results of high dose intravenous urokinase for acute myocardial infarctionThe American Journal of Cardiology, 1990
- Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator. Correlation with characteristics of and clinical outcomes in patients with acute myocardial infarction. The TAMI Study Group.Circulation, 1989
- A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction.Circulation, 1989
- Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarctionThe American Journal of Medicine, 1988
- Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction.Circulation, 1988
- Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinaseJournal of the American College of Cardiology, 1988